Oppenheimer Asset Management Inc. Sells 10,235 Shares of Astera Labs, Inc. $ALAB

Oppenheimer Asset Management Inc. cut its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 66.1% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,244 shares of the company’s stock after selling 10,235 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Astera Labs were worth $1,027,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Great Valley Advisor Group Inc. grew its position in shares of Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after purchasing an additional 90 shares in the last quarter. Rye Brook Capital LLC boosted its stake in shares of Astera Labs by 1.1% in the third quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock valued at $1,801,000 after buying an additional 100 shares during the period. First Horizon Advisors Inc. increased its stake in Astera Labs by 12.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock worth $89,000 after acquiring an additional 108 shares during the period. SlateStone Wealth LLC raised its holdings in Astera Labs by 1.3% in the 3rd quarter. SlateStone Wealth LLC now owns 12,744 shares of the company’s stock valued at $2,495,000 after acquiring an additional 160 shares in the last quarter. Finally, Merit Financial Group LLC lifted its position in shares of Astera Labs by 3.1% during the 3rd quarter. Merit Financial Group LLC now owns 5,683 shares of the company’s stock valued at $1,113,000 after acquiring an additional 170 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Buying and Selling

In related news, Director Manuel Alba sold 150,000 shares of the firm’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the sale, the director owned 1,574,498 shares of the company’s stock, valued at $261,650,077.64. This trade represents a 8.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Jitendra Mohan sold 90,459 shares of the company’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the transaction, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. The trade was a 4.17% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 576,936 shares of company stock worth $87,409,540 in the last ninety days. Insiders own 12.50% of the company’s stock.

Astera Labs Trading Up 2.2%

ALAB opened at $129.32 on Friday. The company has a market cap of $21.84 billion, a P/E ratio of 106.00, a PEG ratio of 2.80 and a beta of 1.50. The company’s 50 day moving average is $164.09 and its 200-day moving average is $174.51. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The firm’s revenue was up 91.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. TD Cowen restated a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Stifel Nicolaus raised their target price on shares of Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Morgan Stanley restated an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a research report on Wednesday, December 3rd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a research report on Wednesday, January 21st. Finally, Northland Securities boosted their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, December 9th. Fourteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $192.89.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 results beat consensus (revenue and EPS ahead) and management gave solid Q1 guidance, supporting the growth narrative tied to AI/hyperscaler demand. ALAB Stock Dips 31% Post Q4 Earnings
• Positive Sentiment: Northland Securities reiterated an Outperform rating and published multi-quarter EPS projections plus a $195 price target — a bullish analyst signal that supports upside if execution continues. MarketBeat – Northland Estimates
• Neutral Sentiment: Several deep-dive writeups and the Q4 earnings transcript are available for investors parsing the details (growth, product cadence, Scorpio X timing). These are useful for assessing whether margin pressures are one-off or structural. Earnings Call Transcript
• Neutral Sentiment: Short-interest reports in the feed show anomalous “0 shares / NaN” values across dates — data appears erroneous and provides no reliable signal on short pressure. (Treat short-interest figures cautiously.)
• Negative Sentiment: Investors sold aggressively after management flagged margin headwinds and rising operating expenses; multiple outlets report a sharp post-earnings drop as traders re-priced the stock despite the beat. ALAB Stock Slides
• Negative Sentiment: Analyst downgrade / notes and reports of a gap-down move amplified the sell-off — negative research and headlines can pressure sentiment even when fundamentals look strong. Shares Gap Down Following Analyst Downgrade
• Negative Sentiment: Coverage pieces explain the paradox: stellar revenue growth but margin guidance and near-term opex make the print look less clean, prompting profit-taking and volatility. Why Stock Crashed Despite Strong Earnings

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.